European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company’s Cangrelor

PARSIPPANY, NJ–(Marketwired – Dec 23, 2013) – The Medicines Company (NASDAQ: MDCO) today announced that the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for the investigational intravenous antiplatelet agent, cangrelor.

Source: http://www.marketwired.com/mw/release.do?id=1864874&sourceType=3